Aldesleukin Completed Phase 1 Trials for Stage II Multiple Myeloma / Refractory Multiple Myeloma / Stage I Multiple Myeloma / Stage III Multiple Myeloma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00002787Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation